Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LANCE: Rosuvastatin/Ezetimibe vs Simvastatin/Ezetimibe in Hypercholesterolemia
NCT01420549Phase 3Completed
- Sponsor
- Aché Laboratórios Farmacêuticos
- Start
- Mar 2013
- Primary completion
- Nov 2014
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in hypercholesterolemia and mixed dyslipidemia comparing Rosuvastatin + Ezetimibe with Simvastatin + Ezetimibe (2 arms). Primary endpoint: Percentage of LDL-C variation at 9 weeks. Started Mar 2013; status: completed.
02
Drugs
rosuvastatinezetimibe
03
Conditions
hypercholesterolemiamixed dyslipidemia
Beyond the preview
Go deeper on NCT01420549.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01420549.